Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.

@article{Ortonne2009QualityOL,
  title={Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.},
  author={Jean-paul Ortonne and Cecilia Ganslandt and J Tan and Peter Nordin and Knud Kragballe and Siegfried Segaert},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2009},
  volume={23 8},
  pages={919-26}
}
BACKGROUND Psoriasis vulgaris of the scalp has a significant psychosocial impact on individuals affecting their quality of life (QoL). A combination of calcipotriol and betamethasone dipropionate in a formulation suitable for treatment of scalp psoriasis has been developed. OBJECTIVE To assess the impact of treatment with either calcipotriol plus betamethasone dipropionate scalp formulation or calcipotriol scalp solution on QoL in patients with scalp psoriasis (both within and between… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Psoriasis Foundation Benchmark Survey

  • HL Richards, DG Fortune, CE Griffiths, CJ. Main
  • Available at: http:// www.psoriasis.org/files…
  • 2007

Similar Papers

Loading similar papers…